Mummified Cells are a Common Finding in Cutaneous Hodgkin Lymphoma and Can Be Used as a Diagnostic Clue.
Journal
The American Journal of dermatopathology
ISSN: 1533-0311
Titre abrégé: Am J Dermatopathol
Pays: United States
ID NLM: 7911005
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
pubmed:
7
6
2019
medline:
3
6
2020
entrez:
7
6
2019
Statut:
ppublish
Résumé
Specific cutaneous involvement in Hodgkin lymphoma is rare. In cutaneous lesions, the diagnosis is usually based on the recognition of diagnostic Reed-Sternberg cells and its variants. In nodal Hodgkin lymphoma, so-called mummified cells (cells with condensed cytoplasm and pyknotic eosinophilic or basophilic nuclei) are often seen. They are sometimes conspicuous and easy to recognize, thus serving as a clue to the diagnosis. Our objective was to study cases of cutaneous Hodgkin lymphoma to identify the occurrence of mummified cells. We studied 12 patients (4 women and 8 men; age range 23-80 years). In 6 patients, cutaneous and extracutaneous disease was identified almost simultaneously; in 4 patients, lymph node disease preceded cutaneous involvement; and in the remaining 2 patients, the skin lesions were the presenting sign, whereas lymph node involvement occurred later. Histopathological, immunohistochemical, and molecular-genetic studies, including rearrangements for TCR, IgH genes, and PCR for EBV, were performed. Cutaneous biopsy specimens revealed either a multinodular or diffuse infiltrate, included small lymphocytes, eosinophils, plasma cells, and macrophages, but in all cases, diagnostic Reed-Sternberg cells and its variants were identified. Mummified cells were detected in 9 cases, either as occasional scattered mummified cells often requiring a search (6 cases) or being conspicuous, grouped and therefore easily identified (3 cases). Immunohistochemically, in all 7 cases studied, mummified cells were positive for both CD30 and CD15. It is concluded that mummified cells are encountered in a majority of cases of cutaneous Hodgkin lymphoma.
Identifiants
pubmed: 31169526
doi: 10.1097/DAD.0000000000001445
pii: 00000372-202001000-00005
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
24-28Références
Smith JL Jr, Butler JJ. Skin involvement in Hodgkin's disease. Cancer. 1980;45:354–361.
White RM, Patterson JW. Cutaneous involvement in Hodgkin's disease. Cancer. 1985;55:1136–1145.
Tassies D, Sierra J, Montserrat E, et al. Specific cutaneous involvement in Hodgkin's disease. Hematol Oncol. 1992;10:75–79.
Moretti S, Pimpinelli N, Di Lollo S, et al. In situ immunologic characterization of cutaneous involvement in Hodgkin's disease. Cancer. 1989;63:661–666.
Sioutos N, Kerl H, Murphy SB, et al. Primary cutaneous Hodgkin's disease. Unique clinical, morphologic, and immunophenotypic findings. Am J Dermatopathol. 1994;16:2–8.
Cerroni L, Beham-Schmid C, Kerl H. Cutaneous Hodgkin's disease: an immunohistochemical analysis. J Cutan Pathol. 1995;22:229–235.
van Dongen JJ, Langerak AW, Brüggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936. Leukemia. 2003;17:2257–2317.
Kazakov DV, Nemcova J, Mikyskova I, et al. Absence of Epstein-Barr virus, human papillomavirus, and simian virus 40 in patients of central european origin with lymphoepithelioma-like carcinoma of the skin. Am J Dermatopathol. 2007;29:365–369.
Watzinger F, Suda M, Preuner S, et al. Real-time quantitative PCR assays for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients. J Clin Microbiol. 2004;42:5189–5198.
Svajdler M Jr, Kaspirkova J, Mezencev R, et al. Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a non-endemic eastern european population. Neoplasma. 2016;63:107–114.
Sternberg C Ueber eine eigenartige unter dem Bilde der Pseudoleukaemie verlaufende Tuberculose des lymphatischen Apparates. Z Heilkunde. 1898;19:21–90.
Reed DM. On the pathological changes in Hodgkin's diease, with especial reference to its relation to tuberculosis. Johns Hopkins Hosp Rep. 1902;10:133–196.
Jackson H, Parker F. Hodgkin's disease II. Pathology. N Engl J Med. 1944;231:35–44.
Cross RM. Hodgkin's disease: histological classification and diagnosis. J Clin Pathol. 1969;22:165–182.
Kodousek R, Tichá V, Tichý M. Selective monocellular necrosis of Hodgkin's/Reed-Sternberg cells and their immunoreactivity to human serum antinuclear antibodies in NS- and MC-types of malignant lymphogranuloma. Neoplasma. 1992;39:205–210.
Lorenzen J, Thiele J, Fischer R. The mummified Hodgkin cell: cell death in Hodgkin's disease. J Pathol. 1997;182:288–298.
Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239–257.
Payne CM, Bernstein C, Bernstein H. Apoptosis overview emphasizing the role of oxidative stress, DNA damage and signal-transduction pathways. Leuk Lymphoma. 1995;19:43–93.
Gru AA, Lu D. Concurrent malignant melanoma and cutaneous involvement by classical Hodgkin lymphoma (CHL) in a 63 year-old man. Diagn Pathol. 2013;8:135.